Wang YL, Bagg A, Pear W, Nowell PC, and Hess JL. Chronic myelogenous leukemia: Laboratory diagnosis and monitoring. Genes, Chromosomes and Cancer, 32, 97-111, 2001

Wang YL, Frauwirth KA, Rangwala SM, Lazar MA, and Thompson CB. Thiazolidinedione-activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. J. Biol. Chem. 277, 31781-8, 2002

Acs G, Wang YL, Raghunath PN, Salscheider MA, and Zhang PJ. The role of different immunostaining patterns in Herceptest interpretation and criteria for gene amplifications as determined by fluorescence in situ hybridization. Appl Immunohistochem Mol Morphol. 11, 222-9, 2003

Gomez M, Wu X, and Wang YL. Detection of BCL2-IGH using single-round PCR assays. Diag Mol Path. 14,17-22, 2005

Wang YL, Lee JW, Cesarman E, Jin DK, and Csernus B. Molecular monitoring of chronic myelogenous leukemia: Identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. J. Mol. Diagn. 8, 231-9, 2006.

Lee JW, Chen Q, Knowles DM, Cesarman E and Wang YL. Beta-glucoronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. J. Mol. Diagn. 8, 385-9, 2006.

Jo SH, Yang C, Miao Q, Marzec M, Wasik MA, Lu P and Wang YL. PPAR gamma promotes lymphocyte survival through its actions on cellular metabolic activities. J. of Immunol. 177, 3737-45, 2006

Yang C, Jo SH, Csernus B, Hyjek E, Liu Y, Chadburn A and Wang YL. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of lymphoma cells by affecting cellular metabolism. Am. J. Pathol. 170, 722-32, 2007

Chen Q, Lu P, Jones AV, Cross NCP, Silver RT, and Wang YL. Amplification refractory mutation system (ARMS), a highly sensitive and simple PCR assay for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders. J. Mol. Diagn. 9, 272-6, 2007.

Jones RG, Bui T, White C, Madesh M, Krawczyk CM, Lindsten T, Hawkins BJ, Kubek S, Frauwirth KA, Wang YL, Conway SJ, Roderick HL, Bootman MD, Shen H, Foskett JK, and Thompson CB. The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis. Immunity 27, 268-80, 2007

Wang YL, Lee JW, Kui JS, Chadburn A, Cross NCP, Knowles DM, and Coleman M. Evaluation of JAK2V617F in B- and T-cell neoplasms: Identification of JAK2V617F mutation of undetermined significance (JMUS) in the bone marrow of three individuals. Acta Haematologica 118, 209-14, 2007

Wang YL, Vandris K, Jones AV, Cross NCP, Christos P, Adriano F, and Silver RT. JAK2 mutations are present in all cases of polycythemia vera. Leukemia. Leukemia 22, 1289, 2008

Wang YL* and Miao Q. To live or to die: Pro-survival activity of PPAR gamma in cancers. PPAR Research. Special Issue on PPARs: A Double-Edged Sword in Cancer Therapy? vol 2008, 1-13, 2008. *Corresponding author.

Yang C, Lu P, Lee FY, Barrientos JC, Leonard JP, Ye F, Zhang D, Knowles DM, and Wang YL. Tyrosine kinase inhibition in diffuse large B-cell lymphoma: Molecular basis for anti-tumor activity and drug resistance of dasatinib. Leukemia. Leukemia. 22, 1755-66, 2008.

Branford S, Fletcher L, Cross NCP, M?ller MC, Hochhaus A, Kim D-W, Radich J, Saglio G, Pane F, Kamel-Reid S, Wang YL, Press RD, Lynch K, Rudzki Z, Goldman JM, and Hughes T. Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood. Prepub 8/6/08.

Lu P, Yang C, Guasparri I, Harrington W, Wang YL*, Cesarman E, and the AIDS Malignancy Clinical Trials Consortium. Early events of B-cell receptor signalling are not essential for the proliferation and viability of AIDS-related lymphoma. Leukemia. In press. *Co-corresponding author